Table of Content

1 Tuberculosis Vaccines Market Overview
1.1 Tuberculosis Vaccines Product Scope
1.2 Tuberculosis Vaccines Segment by Type
1.2.1 Global Tuberculosis Vaccines Sales by Type (2016 & 2021 & 2027)
1.2.2 Immunotherapeutic Vaccines
1.2.3 Booster Vaccines
1.2.4 Others
1.3 Tuberculosis Vaccines Segment by Application
1.3.1 Global Tuberculosis Vaccines Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Tuberculosis Vaccines Market Estimates and Forecasts (2016-2027)
1.4.1 Global Tuberculosis Vaccines Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Tuberculosis Vaccines Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Tuberculosis Vaccines Price Trends (2016-2027)

2 Tuberculosis Vaccines Estimates and Forecasts by Region
2.1 Global Tuberculosis Vaccines Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Tuberculosis Vaccines Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Tuberculosis Vaccines Sales Market Share by Region (2016-2021)
2.2.2 Global Tuberculosis Vaccines Revenue Market Share by Region (2016-2021)
2.3 Global Tuberculosis Vaccines Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Tuberculosis Vaccines Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Tuberculosis Vaccines Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Tuberculosis Vaccines Estimates and Projections (2016-2027)
2.4.2 Europe Tuberculosis Vaccines Estimates and Projections (2016-2027)
2.4.3 China Tuberculosis Vaccines Estimates and Projections (2016-2027)
2.4.4 Japan Tuberculosis Vaccines Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Tuberculosis Vaccines Estimates and Projections (2016-2027)
2.4.6 India Tuberculosis Vaccines Estimates and Projections (2016-2027)

3 Global Tuberculosis Vaccines Competition Landscape by Players
3.1 Global Top Tuberculosis Vaccines Players by Sales (2016-2021)
3.2 Global Top Tuberculosis Vaccines Players by Revenue (2016-2021)
3.3 Global Tuberculosis Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tuberculosis Vaccines as of 2020)
3.4 Global Tuberculosis Vaccines Average Price by Company (2016-2021)
3.5 Manufacturers Tuberculosis Vaccines Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Tuberculosis Vaccines Market Size by Type
4.1 Global Tuberculosis Vaccines Historic Market Review by Type (2016-2021)
4.1.1 Global Tuberculosis Vaccines Sales Market Share by Type (2016-2021)
4.1.2 Global Tuberculosis Vaccines Revenue Market Share by Type (2016-2021)
4.1.3 Global Tuberculosis Vaccines Price by Type (2016-2021)
4.2 Global Tuberculosis Vaccines Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Tuberculosis Vaccines Sales Forecast by Type (2022-2027)
4.2.2 Global Tuberculosis Vaccines Revenue Forecast by Type (2022-2027)
4.2.3 Global Tuberculosis Vaccines Price Forecast by Type (2022-2027)

5 Global Tuberculosis Vaccines Market Size by Application
5.1 Global Tuberculosis Vaccines Historic Market Review by Application (2016-2021)
5.1.1 Global Tuberculosis Vaccines Sales Market Share by Application (2016-2021)
5.1.2 Global Tuberculosis Vaccines Revenue Market Share by Application (2016-2021)
5.1.3 Global Tuberculosis Vaccines Price by Application (2016-2021)
5.2 Global Tuberculosis Vaccines Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Tuberculosis Vaccines Sales Forecast by Application (2022-2027)
5.2.2 Global Tuberculosis Vaccines Revenue Forecast by Application (2022-2027)
5.2.3 Global Tuberculosis Vaccines Price Forecast by Application (2022-2027)

6 North America Tuberculosis Vaccines Market Facts & Figures
6.1 North America Tuberculosis Vaccines Sales by Company
6.1.1 North America Tuberculosis Vaccines Sales by Company (2016-2021)
6.1.2 North America Tuberculosis Vaccines Revenue by Company (2016-2021)
6.2 North America Tuberculosis Vaccines Sales Breakdown by Type
6.2.1 North America Tuberculosis Vaccines Sales Breakdown by Type (2016-2021)
6.2.2 North America Tuberculosis Vaccines Sales Breakdown by Type (2022-2027)
6.3 North America Tuberculosis Vaccines Sales Breakdown by Application
6.3.1 North America Tuberculosis Vaccines Sales Breakdown by Application (2016-2021)
6.3.2 North America Tuberculosis Vaccines Sales Breakdown by Application (2022-2027)

7 Europe Tuberculosis Vaccines Market Facts & Figures
7.1 Europe Tuberculosis Vaccines Sales by Company
7.1.1 Europe Tuberculosis Vaccines Sales by Company (2016-2021)
7.1.2 Europe Tuberculosis Vaccines Revenue by Company (2016-2021)
7.2 Europe Tuberculosis Vaccines Sales Breakdown by Type
7.2.1 Europe Tuberculosis Vaccines Sales Breakdown by Type (2016-2021)
7.2.2 Europe Tuberculosis Vaccines Sales Breakdown by Type (2022-2027)
7.3 Europe Tuberculosis Vaccines Sales Breakdown by Application
7.3.1 Europe 126 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 126 Sales Breakdown by Application (2022-2027)

8 China Tuberculosis Vaccines Market Facts & Figures
8.1 China Tuberculosis Vaccines Sales by Company
8.1.1 China Tuberculosis Vaccines Sales by Company (2016-2021)
8.1.2 China Tuberculosis Vaccines Revenue by Company (2016-2021)
8.2 China Tuberculosis Vaccines Sales Breakdown by Type
8.2.1 China Tuberculosis Vaccines Sales Breakdown by Type (2016-2021)
8.2.2 China Tuberculosis Vaccines Sales Breakdown by Type (2022-2027)
8.3 China Tuberculosis Vaccines Sales Breakdown by Application
8.3.1 China 151 Sales Breakdown by Application (2016-2021)
8.3.2 China 151 Sales Breakdown by Application (2022-2027)

9 Japan Tuberculosis Vaccines Market Facts & Figures
9.1 Japan Tuberculosis Vaccines Sales by Company
9.1.1 Japan Tuberculosis Vaccines Sales by Company (2016-2021)
9.1.2 Japan Tuberculosis Vaccines Revenue by Company (2016-2021)
9.2 Japan Tuberculosis Vaccines Sales Breakdown by Type
9.2.1 Japan Tuberculosis Vaccines Sales Breakdown by Type (2016-2021)
9.2.2 Japan Tuberculosis Vaccines Sales Breakdown by Type (2022-2027)
9.3 Japan Tuberculosis Vaccines Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Tuberculosis Vaccines Market Facts & Figures
10.1 Southeast Asia Tuberculosis Vaccines Sales by Company
10.1.1 Southeast Asia Tuberculosis Vaccines Sales by Company (2016-2021)
10.1.2 Southeast Asia Tuberculosis Vaccines Revenue by Company (2016-2021)
10.2 Southeast Asia Tuberculosis Vaccines Sales Breakdown by Type
10.2.1 Southeast Asia Tuberculosis Vaccines Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Tuberculosis Vaccines Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Tuberculosis Vaccines Sales Breakdown by Application
10.3.1 Southeast Asia K Doses Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Doses Sales Breakdown by Application (2022-2027)

11 India Tuberculosis Vaccines Market Facts & Figures
11.1 India Tuberculosis Vaccines Sales by Company
11.1.1 India Tuberculosis Vaccines Sales by Company (2016-2021)
11.1.2 India Tuberculosis Vaccines Revenue by Company (2016-2021)
11.2 India Tuberculosis Vaccines Sales Breakdown by Type
11.2.1 India Tuberculosis Vaccines Sales Breakdown by Type (2016-2021)
11.2.2 India Tuberculosis Vaccines Sales Breakdown by Type (2022-2027)
11.3 India Tuberculosis Vaccines Sales Breakdown by Application
11.3.1 India Tuberculosis Vaccines Sales Breakdown by Application (2016-2021)
11.3.2 India Tuberculosis Vaccines Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Tuberculosis Vaccines Business
12.1 Sanofi
12.1.1 Sanofi Corporation Information
12.1.2 Sanofi Business Overview
12.1.3 Sanofi Tuberculosis Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Sanofi Tuberculosis Vaccines Products Offered
12.1.5 Sanofi Recent Development
12.2 Merck
12.2.1 Merck Corporation Information
12.2.2 Merck Business Overview
12.2.3 Merck Tuberculosis Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Merck Tuberculosis Vaccines Products Offered
12.2.5 Merck Recent Development
12.3 Serum Institute of India
12.3.1 Serum Institute of India Corporation Information
12.3.2 Serum Institute of India Business Overview
12.3.3 Serum Institute of India Tuberculosis Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Serum Institute of India Tuberculosis Vaccines Products Offered
12.3.5 Serum Institute of India Recent Development
12.4 GlaxoSmithKline
12.4.1 GlaxoSmithKline Corporation Information
12.4.2 GlaxoSmithKline Business Overview
12.4.3 GlaxoSmithKline Tuberculosis Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.4.4 GlaxoSmithKline Tuberculosis Vaccines Products Offered
12.4.5 GlaxoSmithKline Recent Development
12.5 Japan BCG Lab
12.5.1 Japan BCG Lab Corporation Information
12.5.2 Japan BCG Lab Business Overview
12.5.3 Japan BCG Lab Tuberculosis Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Japan BCG Lab Tuberculosis Vaccines Products Offered
12.5.5 Japan BCG Lab Recent Development
12.6 IDT Biologics
12.6.1 IDT Biologics Corporation Information
12.6.2 IDT Biologics Business Overview
12.6.3 IDT Biologics Tuberculosis Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.6.4 IDT Biologics Tuberculosis Vaccines Products Offered
12.6.5 IDT Biologics Recent Development
12.7 GreenSignal Bio Pharma
12.7.1 GreenSignal Bio Pharma Corporation Information
12.7.2 GreenSignal Bio Pharma Business Overview
12.7.3 GreenSignal Bio Pharma Tuberculosis Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.7.4 GreenSignal Bio Pharma Tuberculosis Vaccines Products Offered
12.7.5 GreenSignal Bio Pharma Recent Development
12.8 Taj Pharmaceuticals
12.8.1 Taj Pharmaceuticals Corporation Information
12.8.2 Taj Pharmaceuticals Business Overview
12.8.3 Taj Pharmaceuticals Tuberculosis Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Taj Pharmaceuticals Tuberculosis Vaccines Products Offered
12.8.5 Taj Pharmaceuticals Recent Development
12.9 Bavarian Nordic
12.9.1 Bavarian Nordic Corporation Information
12.9.2 Bavarian Nordic Business Overview
12.9.3 Bavarian Nordic Tuberculosis Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Bavarian Nordic Tuberculosis Vaccines Products Offered
12.9.5 Bavarian Nordic Recent Development
12.10 China National Biotec Group
12.10.1 China National Biotec Group Corporation Information
12.10.2 China National Biotec Group Business Overview
12.10.3 China National Biotec Group Tuberculosis Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.10.4 China National Biotec Group Tuberculosis Vaccines Products Offered
12.10.5 China National Biotec Group Recent Development

13 Tuberculosis Vaccines Manufacturing Cost Analysis
13.1 Tuberculosis Vaccines Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Tuberculosis Vaccines
13.4 Tuberculosis Vaccines Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Tuberculosis Vaccines Distributors List
14.3 Tuberculosis Vaccines Customers

15 Market Dynamics
15.1 Tuberculosis Vaccines Market Trends
15.2 Tuberculosis Vaccines Drivers
15.3 Tuberculosis Vaccines Market Challenges
15.4 Tuberculosis Vaccines Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Tuberculosis Vaccines Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Tuberculosis Vaccines Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Tuberculosis Vaccines Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Tuberculosis Vaccines Sales (K Doses) by Region (2016-2021)
Table 5. Global Tuberculosis Vaccines Sales Market Share by Region (2016-2021)
Table 6. Global Tuberculosis Vaccines Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Tuberculosis Vaccines Revenue Share by Region (2016-2021)
Table 8. Global Tuberculosis Vaccines Sales (K Doses) Forecast by Region (2022-2027)
Table 9. Global Tuberculosis Vaccines Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Tuberculosis Vaccines Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Tuberculosis Vaccines Revenue Share Forecast by Region (2022-2027)
Table 12. Global Tuberculosis Vaccines Sales (K Doses) of Key Companies (2016-2021)
Table 13. Global Tuberculosis Vaccines Sales Share by Company (2016-2021)
Table 14. Global Tuberculosis Vaccines Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Tuberculosis Vaccines Revenue Share by Company (2016-2021)
Table 16. Global Tuberculosis Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis Vaccines as of 2020)
Table 17. Global Tuberculosis Vaccines Average Price (USD/Dose) of Key Company (2016-2021)
Table 18. Manufacturers Tuberculosis Vaccines Manufacturing Sites and Area Served
Table 19. Manufacturers Tuberculosis Vaccines Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Tuberculosis Vaccines Sales (K Doses) by Type (2016-2021)
Table 22. Global Tuberculosis Vaccines Sales Share by Type (2016-2021)
Table 23. Global Tuberculosis Vaccines Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Tuberculosis Vaccines Price (USD/Dose) by Type (2016-2021)
Table 25. Global Tuberculosis Vaccines Sales Share by Type (2022-2027)
Table 26. Global Tuberculosis Vaccines Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Tuberculosis Vaccines Revenue Share by Type (2022-2027)
Table 28. Global Tuberculosis Vaccines Price (USD/Dose) by Type (2022-2027)
Table 29. Global Tuberculosis Vaccines Sales (K Doses) by Application (2016-2021)
Table 30. Global Tuberculosis Vaccines Sales Share by Application (2016-2021)
Table 31. Global Tuberculosis Vaccines Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Tuberculosis Vaccines Price (USD/Dose) by Application (2016-2021)
Table 33. Global Tuberculosis Vaccines Sales (K Doses) by Application (2022-2027)
Table 34. Global Tuberculosis Vaccines Sales Share by Application (2022-2027)
Table 35. Global Tuberculosis Vaccines Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Tuberculosis Vaccines Revenue Share by Application (2022-2027)
Table 37. Global Tuberculosis Vaccines Price (USD/Dose) by Application (2022-2027)
Table 38. North America Tuberculosis Vaccines Sales (K Doses) by Company (2016-2021)
Table 39. North America Tuberculosis Vaccines Sales Market Share by Company (2016-2021)
Table 40. North America Tuberculosis Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Tuberculosis Vaccines Revenue Market Share by Company (2016-2021)
Table 42. North America Tuberculosis Vaccines Sales by Type (2016-2021) & (K Doses)
Table 43. North America Tuberculosis Vaccines Sales Market Share by Type (2016-2021)
Table 44. North America Tuberculosis Vaccines Sales by Type (2022-2027) & (K Doses)
Table 45. North America Tuberculosis Vaccines Sales Market Share by Type (2022-2027)
Table 46. North America Tuberculosis Vaccines Sales by Application (2016-2021) & (K Doses)
Table 47. North America Tuberculosis Vaccines Sales Market Share by Application (2016-2021)
Table 48. North America Tuberculosis Vaccines Sales by Application (2022-2027) & (K Doses)
Table 49. North America Tuberculosis Vaccines Sales Market Share by Application (2022-2027)
Table 50. Europe Tuberculosis Vaccines Sales (K Doses) by Company (2016-2021)
Table 51. Europe Tuberculosis Vaccines Sales Market Share by Company (2016-2021)
Table 52. Europe Tuberculosis Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Tuberculosis Vaccines Revenue Market Share by Company (2016-2021)
Table 54. Europe Tuberculosis Vaccines Sales by Type (2016-2021) & (K Doses)
Table 55. Europe Tuberculosis Vaccines Sales Market Share by Type (2016-2021)
Table 56. Europe Tuberculosis Vaccines Sales by Type (2022-2027) & (K Doses)
Table 57. Europe Tuberculosis Vaccines Sales Market Share by Type (2022-2027)
Table 58. Europe Tuberculosis Vaccines Sales by Application (2016-2021) & (K Doses)
Table 59. Europe Tuberculosis Vaccines Sales Market Share by Application (2016-2021)
Table 60. Europe Tuberculosis Vaccines Sales by Application (2022-2027) & (K Doses)
Table 61. Europe Tuberculosis Vaccines Sales Market Share by Application (2022-2027)
Table 62. China Tuberculosis Vaccines Sales (K Doses) by Company (2016-2021)
Table 63. China Tuberculosis Vaccines Sales Market Share by Company (2016-2021)
Table 64. China Tuberculosis Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Tuberculosis Vaccines Revenue Market Share by Company (2016-2021)
Table 66. China Tuberculosis Vaccines Sales by Type (2016-2021) & (K Doses)
Table 67. China Tuberculosis Vaccines Sales Market Share by Type (2016-2021)
Table 68. China Tuberculosis Vaccines Sales by Type (2022-2027) & (K Doses)
Table 69. China Tuberculosis Vaccines Sales Market Share by Type (2022-2027)
Table 70. China Tuberculosis Vaccines Sales by Application (2016-2021) & (K Doses)
Table 71. China Tuberculosis Vaccines Sales Market Share by Application (2016-2021)
Table 72. China Tuberculosis Vaccines Sales by Application (2022-2027) & (K Doses)
Table 73. China Tuberculosis Vaccines Sales Market Share by Application (2022-2027)
Table 74. Japan Tuberculosis Vaccines Sales (K Doses) by Company (2016-2021)
Table 75. Japan Tuberculosis Vaccines Sales Market Share by Company (2016-2021)
Table 76. Japan Tuberculosis Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Tuberculosis Vaccines Revenue Market Share by Company (2016-2021)
Table 78. Japan Tuberculosis Vaccines Sales by Type (2016-2021) & (K Doses)
Table 79. Japan Tuberculosis Vaccines Sales Market Share by Type (2016-2021)
Table 80. Japan Tuberculosis Vaccines Sales by Type (2022-2027) & (K Doses)
Table 81. Japan Tuberculosis Vaccines Sales Market Share by Type (2022-2027)
Table 82. Japan Tuberculosis Vaccines Sales by Application (2016-2021) & (K Doses)
Table 83. Japan Tuberculosis Vaccines Sales Market Share by Application (2016-2021)
Table 84. Japan Tuberculosis Vaccines Sales by Application (2022-2027) & (K Doses)
Table 85. Japan Tuberculosis Vaccines Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Tuberculosis Vaccines Sales (K Doses) by Company (2016-2021)
Table 87. Southeast Asia Tuberculosis Vaccines Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Tuberculosis Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Tuberculosis Vaccines Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Tuberculosis Vaccines Sales by Type (2016-2021) & (K Doses)
Table 91. Southeast Asia Tuberculosis Vaccines Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Tuberculosis Vaccines Sales by Type (2022-2027) & (K Doses)
Table 93. Southeast Asia Tuberculosis Vaccines Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Tuberculosis Vaccines Sales by Application (2016-2021) & (K Doses)
Table 95. Southeast Asia Tuberculosis Vaccines Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Tuberculosis Vaccines Sales by Application (2022-2027) & (K Doses)
Table 97. Southeast Asia Tuberculosis Vaccines Sales Market Share by Application (2022-2027)
Table 98. India Tuberculosis Vaccines Sales (K Doses) by Company (2016-2021)
Table 99. India Tuberculosis Vaccines Sales Market Share by Company (2016-2021)
Table 100. India Tuberculosis Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Tuberculosis Vaccines Revenue Market Share by Company (2016-2021)
Table 102. India Tuberculosis Vaccines Sales by Type (2016-2021) & (K Doses)
Table 103. India Tuberculosis Vaccines Sales Market Share by Type (2016-2021)
Table 104. India Tuberculosis Vaccines Sales by Type (2022-2027) & (K Doses)
Table 105. India Tuberculosis Vaccines Sales Market Share by Type (2022-2027)
Table 106. India Tuberculosis Vaccines Sales by Application (2016-2021) & (K Doses)
Table 107. India Tuberculosis Vaccines Sales Market Share by Application (2016-2021)
Table 108. India Tuberculosis Vaccines Sales by Application (2022-2027) & (K Doses)
Table 109. India Tuberculosis Vaccines Sales Market Share by Application (2022-2027)
Table 110. Sanofi Corporation Information
Table 111. Sanofi Description and Business Overview
Table 112. Sanofi Tuberculosis Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 113. Sanofi Tuberculosis Vaccines Product
Table 114. Sanofi Recent Development
Table 115. Merck Corporation Information
Table 116. Merck Description and Business Overview
Table 117. Merck Tuberculosis Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 118. Merck Tuberculosis Vaccines Product
Table 119. Merck Recent Development
Table 120. Serum Institute of India Corporation Information
Table 121. Serum Institute of India Description and Business Overview
Table 122. Serum Institute of India Tuberculosis Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 123. Serum Institute of India Tuberculosis Vaccines Product
Table 124. Serum Institute of India Recent Development
Table 125. GlaxoSmithKline Corporation Information
Table 126. GlaxoSmithKline Description and Business Overview
Table 127. GlaxoSmithKline Tuberculosis Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 128. GlaxoSmithKline Tuberculosis Vaccines Product
Table 129. GlaxoSmithKline Recent Development
Table 130. Japan BCG Lab Corporation Information
Table 131. Japan BCG Lab Description and Business Overview
Table 132. Japan BCG Lab Tuberculosis Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 133. Japan BCG Lab Tuberculosis Vaccines Product
Table 134. Japan BCG Lab Recent Development
Table 135. IDT Biologics Corporation Information
Table 136. IDT Biologics Description and Business Overview
Table 137. IDT Biologics Tuberculosis Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 138. IDT Biologics Tuberculosis Vaccines Product
Table 139. IDT Biologics Recent Development
Table 140. GreenSignal Bio Pharma Corporation Information
Table 141. GreenSignal Bio Pharma Description and Business Overview
Table 142. GreenSignal Bio Pharma Tuberculosis Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 143. GreenSignal Bio Pharma Tuberculosis Vaccines Product
Table 144. GreenSignal Bio Pharma Recent Development
Table 145. Taj Pharmaceuticals Corporation Information
Table 146. Taj Pharmaceuticals Tuberculosis Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 147. Taj Pharmaceuticals Description and Business Overview
Table 148. Taj Pharmaceuticals Tuberculosis Vaccines Product
Table 149. Taj Pharmaceuticals Recent Development
Table 150. Bavarian Nordic Corporation Information
Table 151. Bavarian Nordic Tuberculosis Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 152. Bavarian Nordic Description and Business Overview
Table 153. Bavarian Nordic Tuberculosis Vaccines Product
Table 154. Bavarian Nordic Recent Development
Table 155. China National Biotec Group Corporation Information
Table 156. China National Biotec Group Description and Business Overview
Table 157. China National Biotec Group Tuberculosis Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 158. China National Biotec Group Tuberculosis Vaccines Product
Table 159. China National Biotec Group Recent Development
Table 160. Production Base and Market Concentration Rate of Raw Material
Table 161. Key Suppliers of Raw Materials
Table 162. Tuberculosis Vaccines Distributors List
Table 163. Tuberculosis Vaccines Customers List
Table 164. Tuberculosis Vaccines Market Trends
Table 165. Tuberculosis Vaccines Market Drivers
Table 166. Tuberculosis Vaccines Market Challenges
Table 167. Tuberculosis Vaccines Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Tuberculosis Vaccines Product Picture
Figure 2. Global Tuberculosis Vaccines Sales Market Share by Type in 2021 & 2027
Figure 3. Immunotherapeutic Vaccines Product Picture
Figure 4. Booster Vaccines Product Picture
Figure 5. Others Product Picture
Figure 6. Global Tuberculosis Vaccines Sales Market Share by Application in 2021 & 2027
Figure 7. Hospitals Examples
Figure 8. Clinics Examples
Figure 9. Others Examples
Figure 10. Global Tuberculosis Vaccines Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Tuberculosis Vaccines Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Tuberculosis Vaccines Sales (K Doses) Growth Rate (2016-2027)
Figure 13. Global Tuberculosis Vaccines Price Trends Growth Rate (2016-2027) (USD/Dose)
Figure 14. Global Tuberculosis Vaccines Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Tuberculosis Vaccines Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Tuberculosis Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Tuberculosis Vaccines Sales (K Doses) Growth Rate (2016-2027)
Figure 18. Europe Tuberculosis Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Tuberculosis Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Tuberculosis Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Tuberculosis Vaccines Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Tuberculosis Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Tuberculosis Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Tuberculosis Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Tuberculosis Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Tuberculosis Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Tuberculosis Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Tuberculosis Vaccines Players Market Share by Revenue in Tuberculosis Vaccines: 2016 & 2020
Figure 29. Tuberculosis Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Tuberculosis Vaccines Revenue Share by Type (2016-2021)
Figure 31. Global Tuberculosis Vaccines Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Tuberculosis Vaccines Revenue Share by Application (2016-2021)
Figure 33. Global Tuberculosis Vaccines Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Tuberculosis Vaccines Sales Market Share by Type in 2020
Figure 35. North America Tuberculosis Vaccines Sales Market Share by Application in 2020
Figure 36. Europe Tuberculosis Vaccines Sales Market Share by Type in 2020
Figure 37. Europe Tuberculosis Vaccines Sales Market Share by Application in 2020
Figure 38. China Tuberculosis Vaccines Sales Market Share by Type in 2020
Figure 39. China Tuberculosis Vaccines Sales Market Share by Application in 2020
Figure 40. Japan Tuberculosis Vaccines Sales Market Share by Type in 2020
Figure 41. Japan Tuberculosis Vaccines Sales Market Share by Application in 2020
Figure 42. Southeast Asia Tuberculosis Vaccines Sales Market Share by Type in 2020
Figure 43. Southeast Asia Tuberculosis Vaccines Sales Market Share by Application in 2020
Figure 44. India Tuberculosis Vaccines Sales Market Share by Type in 2020
Figure 45. India Tuberculosis Vaccines Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Tuberculosis Vaccines
Figure 48. Manufacturing Process Analysis of Tuberculosis Vaccines
Figure 49. Tuberculosis Vaccines Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed